Malaria Diagnostics Market Is Predicted To Grow Swiftly Due To Rising Prevalence Of The Disease Worldwide Till 2022: Grand View Research, Inc.
The malaria diagnostics market was worth USD 579.5 million in
2015 owing to rising prevalence of the disease worldwide. The market is
projected to reach USD 789.0 million over the forecast period. In addition to
growing need for technological advancements, there is rising demand for
cost-efficient and high-quality diagnostics methodologies that can trigger
growth in the industry.
The
diagnostics market can be segmented into rapid diagnostic tests (RDTs) and
microscopic devices. RDT malaria diagnostic market accounted for a share of
about 45.0% in the year 2015, in terms of revenue and is expected to continue
the trend with the highest CAGR over the forecast period. Need for faster
results, growing sensitivity and shortage of skilled workforce are key factors
driving the industry. Also, RDTs require less turnaround time and are
comparatively simple to use, which is expected to propel demand. The
microscopic malaria diagnostics share, by volume, is anticipated to grow at a
CAGR of about 3.7% over the next seven years.
Rising
poverty, improper weather conditions, inadequate medical facilities, and high
prevalence of, P. falciparum have resulted in increased rate of malaria in
Africa. The region contributed to over 58.0% by volume in 2015 and is expected
to witness a rise in the share to reach about 60.0% by 2022.
Microscopy
technology dominated the MD market with more than 190 million patients
diagnosed by this methodology in 2013. India was the key market for this
technology and witnessed about 120 slide examinations in 2013. The MD industry
in the economy is expected to grow at 3.85% over the forecast period.
Africa
malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
Browse full
research report on Malaria Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
South-East Asia occupied the second largest share
globally and is projected to increase at a CAGR of about 4.0% from 2015 to
2022. Countries including Sri Lanka have witnessed a decrease in malaria
occurrences by focusing on prevention of the disease via reintroduction phase.
The industry is consolidated with few companies
occupying the dominant share in the market. The companies have been involved in
new product development through technological innovation, collaborations,
partnerships and joint ventures. In March 2015, Standard Diagnostics/Alere
extended their alliance with FIND that involves developing a pioneering RDT for
malaria along with human African trypanosomiasis commonly known as sleeping
sickness. Some key players include Access Bio Inc., Premier Medical
Corporation, bioMerieux, and Beckman Coulter Inc.
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global malaria diagnostics market
on the basis of technology and region:
Global
Malaria Diagnostics Technology Outlook (Volume, Million Units; Revenue, USD
Million, 2012 - 2022)
- Microscopy
- Rapid
Diagnostics Tests (RDT)
- Others
Malaria
Diagnostics Regional Outlook (Volume, Million Units; Revenue, USD Million, 2012
- 2022)
- Africa
- South-East
Asia
- Eastern
Mediterranean
- Europe
- Americas
- Western
Pacific
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-malaria-diagnostics-market
About Grand View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment